Britannia Life Sciences Inc.

CNSX:BLAB Stock Report

Market Cap: CA$13.8m

Britannia Life Sciences Management

Management criteria checks 3/4

Britannia Life Sciences' CEO is Pete Shippen, appointed in Jan 2019, has a tenure of 5.92 years. total yearly compensation is CA$215.40K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 22.84% of the company’s shares, worth CA$3.15M. The average tenure of the management team and the board of directors is 3.1 years and 3.1 years respectively.

Key information

Pete Shippen

Chief executive officer

CA$215.4k

Total compensation

CEO salary percentage100.0%
CEO tenure5.9yrs
CEO ownership22.8%
Management average tenure3.1yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Britannia Life Sciences (CSE:BLAB) Shareholders Will Want The ROCE Trajectory To Continue

Mar 01
Britannia Life Sciences (CSE:BLAB) Shareholders Will Want The ROCE Trajectory To Continue

Britannia Life Sciences (CSE:BLAB) Might Have The Makings Of A Multi-Bagger

Nov 14
Britannia Life Sciences (CSE:BLAB) Might Have The Makings Of A Multi-Bagger

Returns At Britannia Life Sciences (CSE:BLAB) Appear To Be Weighed Down

Apr 19
Returns At Britannia Life Sciences (CSE:BLAB) Appear To Be Weighed Down

A Look At The Fair Value Of Britannia Life Sciences Inc. (CSE:BLAB)

Mar 13
A Look At The Fair Value Of Britannia Life Sciences Inc. (CSE:BLAB)

CEO Compensation Analysis

How has Pete Shippen's remuneration changed compared to Britannia Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$7m

Jun 30 2024n/an/a

-CA$5m

Mar 31 2024CA$215kCA$215k

-CA$5m

Dec 31 2023n/an/a

CA$2m

Sep 30 2023n/an/a

CA$1m

Jun 30 2023n/an/a

CA$2m

Mar 31 2023CA$211kCA$211k

CA$5m

Dec 31 2022n/an/a

-CA$795k

Sep 30 2022n/an/a

-CA$11m

Jun 30 2022n/an/a

-CA$13m

Mar 31 2022CA$34kCA$34k

-CA$15m

Compensation vs Market: Pete's total compensation ($USD149.23K) is about average for companies of similar size in the Canadian market ($USD163.44K).

Compensation vs Earnings: Pete's compensation has increased whilst the company is unprofitable.


CEO

Pete Shippen (43 yo)

5.9yrs

Tenure

CA$215,400

Compensation

Mr. Peter James Shippen, also known as Pete, CPA, CAIA, serves as Director of Myplas USA, Inc. He serves as Independent Chairman of the Board at Canadian Gold Corp. (formerly known as Satori Resources Inc....


Leadership Team

NamePositionTenureCompensationOwnership
Peter Shippen
CEO & Director5.9yrsCA$215.40k22.84%
CA$ 3.1m
Sarah Zilik
Secretary & CFO3.1yrsCA$132.00kno data
Mark Bowes-Cavanagh
Chief Technical Officer3.1yrsCA$172.00k11.46%
CA$ 1.6m
Boris Novansky
President5.9yrsno datano data
Micah Simmons
Vice President of Corporate Development2.8yrsno datano data

3.1yrs

Average Tenure

44yo

Average Age

Experienced Management: BLAB's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Shippen
CEO & Director3.1yrsCA$215.40k22.84%
CA$ 3.1m
Scott Secord
Independent Director3.1yrsCA$10.00k2.48%
CA$ 341.7k
Greg Taylor
Independent Chairman3.1yrsCA$10.00kno data

3.1yrs

Average Tenure

49yo

Average Age

Experienced Board: BLAB's board of directors are considered experienced (3.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 14:09
End of Day Share Price 2024/12/16 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Britannia Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution